CVLT Shareholder Alert: Commvault Systems, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Commvault's SEC Filings Allegedly Contained Generic Risk Warnings That Failed to Disclose Specific, Known Problems With ARR Growth Calculations, Costing CVLT Investors $40.23 Per Share When the Truth Emerged

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP examines the adequacy of Commvault Systems, Inc.'s (NASDAQ: CVLT) risk disclosures during the period from April 29, 2025 through January 26, 2026. A securities class action has been filed in the United States District Court for the District of New Jersey on behalf of stockholders who suffered losses. Find out if you qualify to recover your investment losses. You may also contact Joseph E. Levi, Esq. at [e-mail] or [phone].

CVLT shares collapsed 31%, falling $40.23 per share from $129.36 to $89.13 on January 27, 2026, after the company disclosed that quarterly net new ARR of $39 million missed the $45 million target management had set just months earlier. The lead plaintiff deadline is July 17, 2026.

What the Company Disclosed to Investors

Throughout the Class Period, Commvault's public filings and earnings presentations included forward-looking statements about ARR growth expectations. Management raised total ARR growth guidance twice, from 16%-17% in April 2025, to 18% in July, and then to 18%-19% in October. The complaint challenges whether these projections were accompanied by meaningful cautionary language identifying the specific factors that could cause actual results to fall short.

What the Action Alleges Was Missing From Disclosures

The securities action contends that Commvault's disclosures omitted critical information investors needed to evaluate the reliability of ARR guidance:

• ARR growth was dependent on the mix of SaaS versus term-license sales, with SaaS deals landing at average selling prices 2 to 3 times lower than software licenses
• The Company allegedly failed to disclose that a shift toward SaaS deals, which constituted 70% of net new ARR by Q3, would mechanically dilute total ARR growth figures
• Longer-duration term-license deals carried price concessions and negatively impacted ARR calculations (computed as total contract value divided by duration), a factor allegedly not disclosed alongside raised guidance
• The complaint asserts that forward-looking statements about $40 million and then $45 million quarterly net new ARR targets were not identified as forward-looking when made and lacked meaningful cautionary statements

Why Generic Warnings May Not Have Protected Investors

The complaint specifically alleges that the statutory safe harbor for forward-looking statements does not apply because the projections at issue were not labeled as forward-looking when made and contained no meaningful cautionary language identifying important factors that could cause actual results to differ materially. As pleaded in the action, Commvault's ARR guidance was presented with increasing confidence each quarter while the mathematical relationship between SaaS deal mix and ARR output was already known internally.

"Generic risk factor language cannot substitute for disclosing specific, known problems that are already affecting a company's operations. When a company raises guidance over multiple consecutive quarters while aware that product mix dynamics could undermine those very targets, investors deserve specific disclosure of that risk." -- Joseph E. Levi, Esq.

Speak with an attorney about whether Commvault's disclosures met legal standards or call [phone].

LEAD PLAINTIFF DEADLINE: July 17, 2026

ABOUT LEVI & KORSINSKY, LLP -- Levi & Korsinsky, LLP, Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered for investors.

Frequently Asked Questions About the CVLT Lawsuit

Q: What specific misstatements does the CVLT lawsuit allege? A: The complaint alleges Commvault made materially false or misleading statements regarding its ARR growth guidance for fiscal year 2026, failing to disclose that the growth was dependent on the mix of SaaS versus term-license sales and that SaaS deals carry significantly lower average selling prices. When the true state was revealed on January 27, 2026, the stock price declined sharply.

Q: When did Commvault allegedly mislead investors? A: The class period runs from April 29, 2025 to January 26, 2026. During this time, management raised ARR growth guidance multiple times before the January 27, 2026 corrective disclosure revealed the guidance was allegedly built on flawed assumptions.

Q: What do CVLT investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [e-mail] or [phone]. No immediate action is required to remain eligible as a class member.

Q: What if I already sold my CVLT shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.

Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.

Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: What if I missed the lead plaintiff deadline? A: The deadline applies only to investors seeking lead plaintiff appointment. Class members who miss it can still participate in any settlement or recovery.